Can you take enclomiphene long-term?

How enclomiphene works

Enclomiphene is one of the two mirror-image components of clomiphene, a fertility drug approved for women. Clomiphene's FDA label describes it as a mix of zuclomiphene and enclomiphene.

Enclomiphene blocks estrogen's feedback signal at the brain. The pituitary responds by releasing more LH and FSH, which prompts the testes to make more testosterone and keep producing sperm. That's the opposite of testosterone therapy, which suppresses LH and FSH.

What the short-term evidence shows

Two phase III trials published in BJU International compared enclomiphene with testosterone gel over 16 weeks in overweight men with secondary hypogonadism. Both treatments raised testosterone. Enclomiphene also raised LH and FSH and kept sperm concentration in the normal range, while the gel reduced sperm production.

Those results explain enclomiphene's appeal for men who want to keep fertility options open. But 16 weeks is a short window, and the trials weren't designed to detect uncommon or slow-developing problems.

Why the long-term data gap exists

Enclomiphene is not FDA-approved for any use. At HealifyMD it's part of a compounded orally dissolving tablet with DHEA, boron and pregnenolone; compounded medications are not FDA-approved, FDA doesn't verify their safety, effectiveness or quality, and they aren't equivalent to any branded product.

In 2022, FDA's Pharmacy Compounding Advisory Committee voted 4 to 8 against adding enclomiphene citrate to the list of bulk substances that 503A pharmacies may compound. Yet FDA's nominations list, updated in May 2026, still shows enclomiphene citrate in Category 1 (under evaluation), so its compounding status remains unsettled. Without an approved product, there's also no system of post-marketing safety reports that builds up over years of use.

The open questions that matter most

• Bone: in men, estrogen plays a major role in maintaining bone density. Enclomiphene blocks estrogen receptors in some tissues, and its effect on bone over years hasn't been studied.
• Vision: clomiphene's label warns of blurring, spots or flashes and other visual symptoms that rise with dose and duration, and states they may be irreversible, especially with higher doses or longer use. Whether enclomiphene alone carries the same risk long term isn't established.
• Heart and metabolism: long-term cardiovascular, lipid and blood sugar effects aren't known.
• Prostate and red blood cells: higher testosterone may raise hematocrit and affect PSA, as with other ways of raising testosterone.
• Mood: mood changes are reported with drugs in this class.

Who tends to be a better or worse fit

Enclomiphene only works if the testes can respond to LH and FSH, so it's aimed at secondary hypogonadism, where the signal from the brain is low. Men with primary testicular failure won't benefit, which is why the AUA guideline calls for measuring LH in men with low testosterone.

It's often considered by men who want to preserve fertility, who prefer a pill to injections, or who want to see whether their own system can be nudged back into range. It's a weaker fit if you've had visual problems with similar drugs, if your hematocrit is already high, or if you're unwilling to commit to regular labs.

What monitoring looks like

Report any visual symptom right away rather than waiting for a scheduled visit. The clomiphene label advises stopping and getting a prompt eye examination if visual symptoms occur.

• Testosterone, LH and FSH, to confirm the medicine is doing what it should.
• Estradiol, since enclomiphene can raise it, sometimes with breast tenderness.
• Hematocrit and PSA, as with any testosterone-raising treatment.
• Lipids and blood sugar.
• Direct questions about vision and mood at every review.

A sensible way to live with uncertainty

Set a clear reason for treatment at the start, and a review interval rather than automatic renewal. At each review, check whether the original reason still applies. Reversible contributors to low testosterone, such as excess weight, sleep apnea, opioid use, heavy drinking or thyroid problems, are worth revisiting, because addressing them may reduce or remove the need for medication.

Decide in advance what would make you stop: a vision change, a worrying lab trend, side effects or no meaningful symptom benefit.

Enclomiphene versus testosterone therapy

Testosterone therapy has decades of use and large studies behind it, but it suppresses sperm production. Enclomiphene preserves fertility but rests on a much thinner evidence base. Neither choice is right for everyone. Your HealifyMD clinician can walk through both. Testosterone Replacement Therapy at HealifyMD is listed at $249 for the first month, including the lab panel, then $149/month; the Enclomiphene / DHEA / Boron / Pregnenolone ODT is listed from $129/month. Prices are confirmed at your eligibility review, and other labs are priced separately.